Trial NCT01680796

View at ClinicalTrials.gov 
Org. Study IDs: CTKI258AU012T

Last trial update was posted on 2013-02-20

MeSH Interventions

Bortezomib Dexamethasone

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

The target drug, dovitinib, failed as a single agent in prior studies in patients with heavily treated multiple myeloma.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID